|
|
|
Insider
Information: |
Young Richard A |
Relationship: |
Director |
City: |
Bridgewater |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
812,186 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,705,800 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
812,186 |
|
|
Total
Value |
$1,705,800 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Enzon Pharmaceuticals Inc |
ENZN |
Director |
2012-07-02 |
30,231 |
2010-04-19 |
0 |
Premium* |
|
Syros Pharmaceuticals, Inc. |
SYRS |
|
2024-06-05 |
42,837 |
|
0 |
Premium* |
|
Omega Therapeutics, Inc. |
OMGA |
Director |
2023-06-02 |
739,118 |
2022-09-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2016-06-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
533,332 |
|
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Director |
|
2010-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
7,137 |
7,137 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Director |
|
2010-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,043 |
14,180 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Director |
|
2011-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,382 |
21,562 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Director |
|
2012-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,669 |
30,231 |
0 |
- |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
36,171 |
0 |
- |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2023-09-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,666 |
38,837 |
0 |
- |
|
SYRS |
Syros Pharmaceuticals, In... |
|
|
2024-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
42,837 |
0 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
Director |
|
2012-03-15 |
4 |
S |
$6.92 |
$13,842 |
D/D |
(2,000) |
19,562 |
0 |
- |
|
OMGA |
Omega Therapeutics, Inc. |
Director |
|
2022-09-14 |
4 |
AS |
$8.00 |
$80,000 |
D/D |
(10,000) |
784,118 |
0 |
% |
|
OMGA |
Omega Therapeutics, Inc. |
Director |
|
2023-01-10 |
4 |
AS |
$8.00 |
$160,000 |
D/D |
(20,000) |
764,118 |
0 |
% |
|
OMGA |
Omega Therapeutics, Inc. |
Director |
|
2023-03-17 |
4 |
AS |
$8.00 |
$80,000 |
D/D |
(10,000) |
754,118 |
0 |
% |
|
OMGA |
Omega Therapeutics, Inc. |
Director |
|
2023-04-06 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
749,118 |
0 |
% |
|
OMGA |
Omega Therapeutics, Inc. |
Director |
|
2023-05-01 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
744,118 |
0 |
% |
|
OMGA |
Omega Therapeutics, Inc. |
Director |
|
2023-06-02 |
4 |
AS |
$8.00 |
$40,000 |
D/D |
(5,000) |
739,118 |
0 |
% |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2020-04-15 |
4 |
AS |
$8.75 |
$209,650 |
D/D |
(23,960) |
371,141 |
0 |
% |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2020-06-15 |
4 |
AS |
$8.75 |
$52,413 |
D/D |
(5,990) |
359,161 |
0 |
% |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2020-10-15 |
4 |
AS |
$8.75 |
$2,774 |
D/D |
(317) |
340,874 |
0 |
% |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2020-10-19 |
4 |
AS |
$8.75 |
$49,639 |
D/D |
(5,673) |
335,201 |
0 |
% |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2020-11-17 |
4 |
AS |
$8.75 |
$46,874 |
D/D |
(5,357) |
339,211 |
0 |
% |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2020-11-17 |
4/A |
AS |
$8.75 |
$46,874 |
D/D |
(5,357) |
329,211 |
0 |
- |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2020-11-16 |
4/A |
AS |
$8.98 |
$5,684 |
D/D |
(633) |
334,568 |
0 |
- |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2020-11-16 |
4 |
AS |
$8.98 |
$5,684 |
D/D |
(633) |
344,568 |
0 |
% |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2020-05-15 |
4 |
AS |
$9.22 |
$55,242 |
D/D |
(5,990) |
365,151 |
0 |
% |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2019-08-15 |
4 |
AS |
$10.00 |
$23,000 |
D/D |
(2,300) |
417,801 |
0 |
- |
|
33 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|